» Articles » PMID: 3355242

Chronic Neurological Sequelae of Acute Organophosphate Pesticide Poisoning

Overview
Date 1988 Jan 1
PMID 3355242
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the latent neurological effects of organophosphate pesticide poisoning, this epidemiologic study examined 100 matched-pairs of individuals with previous acute organophosphate pesticide poisoning and nonpoisoned controls. No significant difference between poisoned subjects and controls was found on audiometric tests, ophthalmic tests, electroencephalograms, or the clinical serum and blood chemistry evaluations. Of the more than 50 scores from the neurological examination, abnormalities were demonstrated among the cases only on measures of memory, abstraction, and mood, and on one test of motor reflexes. Differences between the two cohorts were much more apparent in the neuropsychological tests. The differences occurred on tests of widely varying abilities including intellectual functioning, academic skills, abstraction and flexibility of thinking, and simple motor skills. Twice as many cases as controls (24 vs. 12) had Halstead-Reitan Battery summary scores in the range characteristic of individuals with cerebral damage or dysfunction. Results from the Minnesota Multiphasic Personality Inventory and the Patient's and Relative's Assessment of Patient Functioning Inventories also revealed greater distress and complaints of disability for the poisoned subjects.

Citing Articles

Neurological manifestations of encephalitic alphaviruses, traumatic brain injuries, and organophosphorus nerve agent exposure.

VanderGiessen M, de Jager C, Leighton J, Xie H, Theus M, Johnson E Front Neurosci. 2024; 18:1514940.

PMID: 39734493 PMC: 11671522. DOI: 10.3389/fnins.2024.1514940.


A longitudinal MRI and TSPO PET-based investigation of brain region-specific neuroprotection by diazepam versus midazolam following organophosphate-induced seizures.

Hobson B, Rowland D, Dou Y, Saito N, Harmany Z, Bruun D Neuropharmacology. 2024; 251:109918.

PMID: 38527652 PMC: 11250911. DOI: 10.1016/j.neuropharm.2024.109918.


A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate.

Pirollo K, Moghe M, Guan M, Rait A, Wang A, Kim S Int J Nanomedicine. 2024; 19:307-326.

PMID: 38229703 PMC: 10790653. DOI: 10.2147/IJN.S443498.


Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-Induced Long-Term Neurological Dysfunction, Neurodegeneration, and Neuroinflammation.

Reddy D, Singh T, Ramakrishnan S, Huber M, Wu X J Pharmacol Exp Ther. 2023; 388(2):399-415.

PMID: 38071567 PMC: 10801736. DOI: 10.1124/jpet.123.001819.


Protective Activity of Novel Hydrophilic Synthetic Neurosteroids on Organophosphate Status Epilepticus-induced Chronic Epileptic Seizures, Non-Convulsive Discharges, High-Frequency Oscillations, and Electrographic Ictal Biomarkers.

Ramakrishnan S, Singh T, Reddy D J Pharmacol Exp Ther. 2023; 388(2):386-398.

PMID: 38050069 PMC: 10801763. DOI: 10.1124/jpet.123.001817.